Skip to main content
. 2015 Dec;240(12):1572–1579. doi: 10.1177/1535370215577582

Table 1.

Effect of candesartan and stem cells on renal function tests of cisplatin-treated rats

Group Normal Cisplatin Candesartan Stem Cells
Creatinine (mg/dL) .4 ± .03 1.72 ± .05* .87 ± .02 .6 ± .01
BUN (mg/dL) 28.31 ± .44 79.76 ± .75* 47.27 ± .41 44.15 ± 1.07

Note: All results were expressed as Mean ± SD.

*

Significant difference from Normal group at P < 0.05.

Significant difference from Cisplatin group at P < 0.05.

HHS Vulnerability Disclosure